Characterization of Hyperpolarized Pyruvate MRI Reproducibility
Part of paid clinical trials in Montvale, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT02421380
- Status
- Recruiting
Conditions
- Malignant Solid Tumors
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hyperpolarized Pyruvate — DRUG
Study Details
The purpose of the study is to test a new approach to see if the test results can be reproduced each time the Magnetic resonance imaging (MRI) is done for an individual patient. The study will explore the use of an imaging agent called hyperpolarized \[1-13C\] pyruvate (HP) with MRI scans. (MRI) is a technique that takes pictures of the body's organs using a magnetic field and radiofrequency waves that cannot be felt. In order to accomplish the goal of the study the patient will have two hyperpolarized MRI scans to assess if scans can be reproduced. The hyperpolarized MRI scans will be compared with the pathological results of the surgery to see if the hyperpolarized MRI provides additional information regarding disease metabolism.
Key Dates
- Start date
- Apr 30, 2015
- Status verified
- Nov 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 109 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Hyperpolarized Pyruvate MRI ReproducibilityThis is a reproducibility study of hyperpolarized \[1-13C\] pyruvate MRI in patients with solid tumors. A total of 100 patients will be enrolled, 50 of whom will be imaged using 1D MR spectroscopy and the other 50 with 3D imaging sequence.
Primary Outcome Measure
validate HP MRI at MSKCC (are the scans able to be reproduced) [ Time Frame: 1 year ]
Central Contacts
- Kayvan Keshari, PhD646-888-3631
- Vesselin Miloushev, MD212-639-3087
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Bergen (Consent only ) | Montvale | New Jersey | 07645 | Kayvan Keshari, PhD 646-888-3631 |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Kayvan Keshari, PhD 646-888-3631 Vesselin Miloushev, MD 212-639-3087 |
Find similar trials in Montvale, NJ
Related Studies
- A Study of TAK-505 in Adults With Solid TumorsPHASE1/PHASE2 · Recruiting · Takeda · Orange, California
- Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid TumorsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid LeukemiaPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas